Design
Review
May prompt caution with EU-approved high-risk devices; leaves open optimal regulatory balance for cardiovascular innovation.
As compared with Europe, the United States generally requires more rigorous clinical testing of high-risk devices, which delays patients' access to new devices but may provide better assurance of device safety.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: